Annual Drug Patent Expiration for GALAFOLD
Galafold is a drug marketed by Amicus Therap Us and included in one NDA. It is available from a single supplier. There are forty-six patents protecting this drug.
Drug patent litigation for GALAFOLD.
This drug has one hundred and thirty-nine patent family members in twenty-seven countries.
The generic ingredients in GALAFOLD are migalastat hydrochloride. One registered supplier for this compound. Additional details are available on the migalastat hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Copyright © DrugPatentWatch. Originally published in New patent for the drug Amicus Therap GALAFOLD